Literature DB >> 25753438

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

Pelagia G Tsoutsou1, Jean Bourhis2, George Coukos3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25753438     DOI： 10.1200/JCO.2014.59.2808

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.

Authors:  Giulia Bottai; Carlotta Raschioni; Agnese Losurdo; Luca Di Tommaso; Corrado Tinterri; Rosalba Torrisi; Jorge S Reis-Filho; Massimo Roncalli; Christos Sotiriou; Armando Santoro; Alberto Mantovani; Sherene Loi; Libero Santarpia
Journal:  Breast Cancer Res       Date:  2016-12-03       Impact factor: 6.466

2.  Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Authors:  H Raza Ali; Aliakbar Dariush; Elena Provenzano; Helen Bardwell; Jean E Abraham; Mahesh Iddawela; Anne-Laure Vallier; Louise Hiller; Janet A Dunn; Sarah J Bowden; Tamas Hickish; Karen McAdam; Stephen Houston; Mike J Irwin; Paul D P Pharoah; James D Brenton; Nicholas A Walton; Helena M Earl; Carlos Caldas
Journal:  Breast Cancer Res       Date:  2016-02-16       Impact factor: 6.466

3.  Relapse-related molecular signature in early-stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor-infiltrating lymphocytes.

Authors:  Bo Yang; Wen Rao; Hao Luo; Liang Zhang; Dong Wang
Journal:  Cancer Sci       Date:  2020-08-04       Impact factor: 6.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.